Quality of reporting in AI cardiac MRI segmentation studies - A systematic review and recommendations for future studies.
artificial intelligence
cardiac MRI
machine learning
quality
reporting
segmentation
systematic review
Journal
Frontiers in cardiovascular medicine
ISSN: 2297-055X
Titre abrégé: Front Cardiovasc Med
Pays: Switzerland
ID NLM: 101653388
Informations de publication
Date de publication:
2022
2022
Historique:
received:
30
05
2022
accepted:
30
06
2022
entrez:
1
8
2022
pubmed:
2
8
2022
medline:
2
8
2022
Statut:
epublish
Résumé
There has been a rapid increase in the number of Artificial Intelligence (AI) studies of cardiac MRI (CMR) segmentation aiming to automate image analysis. However, advancement and clinical translation in this field depend on researchers presenting their work in a transparent and reproducible manner. This systematic review aimed to evaluate the quality of reporting in AI studies involving CMR segmentation. MEDLINE and EMBASE were searched for AI CMR segmentation studies in April 2022. Any fully automated AI method for segmentation of cardiac chambers, myocardium or scar on CMR was considered for inclusion. For each study, compliance with the Checklist for Artificial Intelligence in Medical Imaging (CLAIM) was assessed. The CLAIM criteria were grouped into study, dataset, model and performance description domains. 209 studies published between 2012 and 2022 were included in the analysis. Studies were mainly published in technical journals (58%), with the majority (57%) published since 2019. Studies were from 37 different countries, with most from China (26%), the United States (18%) and the United Kingdom (11%). Short axis CMR images were most frequently used (70%), with the left ventricle the most commonly segmented cardiac structure (49%). Median compliance of studies with CLAIM was 67% (IQR 59-73%). Median compliance was highest for the model description domain (100%, IQR 80-100%) and lower for the study (71%, IQR 63-86%), dataset (63%, IQR 50-67%) and performance (60%, IQR 50-70%) description domains. This systematic review highlights important gaps in the literature of CMR studies using AI. We identified key items missing-most strikingly poor description of patients included in the training and validation of AI models and inadequate model failure analysis-that limit the transparency, reproducibility and hence validity of published AI studies. This review may support closer adherence to established frameworks for reporting standards and presents recommendations for improving the quality of reporting in this field. [www.crd.york.ac.uk/prospero/], identifier [CRD42022279214].
Sections du résumé
Background
UNASSIGNED
There has been a rapid increase in the number of Artificial Intelligence (AI) studies of cardiac MRI (CMR) segmentation aiming to automate image analysis. However, advancement and clinical translation in this field depend on researchers presenting their work in a transparent and reproducible manner. This systematic review aimed to evaluate the quality of reporting in AI studies involving CMR segmentation.
Methods
UNASSIGNED
MEDLINE and EMBASE were searched for AI CMR segmentation studies in April 2022. Any fully automated AI method for segmentation of cardiac chambers, myocardium or scar on CMR was considered for inclusion. For each study, compliance with the Checklist for Artificial Intelligence in Medical Imaging (CLAIM) was assessed. The CLAIM criteria were grouped into study, dataset, model and performance description domains.
Results
UNASSIGNED
209 studies published between 2012 and 2022 were included in the analysis. Studies were mainly published in technical journals (58%), with the majority (57%) published since 2019. Studies were from 37 different countries, with most from China (26%), the United States (18%) and the United Kingdom (11%). Short axis CMR images were most frequently used (70%), with the left ventricle the most commonly segmented cardiac structure (49%). Median compliance of studies with CLAIM was 67% (IQR 59-73%). Median compliance was highest for the model description domain (100%, IQR 80-100%) and lower for the study (71%, IQR 63-86%), dataset (63%, IQR 50-67%) and performance (60%, IQR 50-70%) description domains.
Conclusion
UNASSIGNED
This systematic review highlights important gaps in the literature of CMR studies using AI. We identified key items missing-most strikingly poor description of patients included in the training and validation of AI models and inadequate model failure analysis-that limit the transparency, reproducibility and hence validity of published AI studies. This review may support closer adherence to established frameworks for reporting standards and presents recommendations for improving the quality of reporting in this field.
Systematic Review Registration
UNASSIGNED
[www.crd.york.ac.uk/prospero/], identifier [CRD42022279214].
Identifiants
pubmed: 35911553
doi: 10.3389/fcvm.2022.956811
pmc: PMC9334661
doi:
Types de publication
Systematic Review
Langues
eng
Pagination
956811Subventions
Organisme : Wellcome Trust
ID : 205188/Z/16/Z
Pays : United Kingdom
Organisme : British Heart Foundation
ID : SP/14/6/31350
Pays : United Kingdom
Organisme : British Heart Foundation
ID : NH/17/1/32725
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UP_1605/13
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/M008894/1
Pays : United Kingdom
Informations de copyright
Copyright © 2022 Alabed, Maiter, Salehi, Mahmood, Daniel, Jenkins, Goodlad, Sharkey, Mamalakis, Rakocevic, Dwivedi, Assadi, Wild, Lu, O’Regan, van der Geest, Garg and Swift.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Front Cardiovasc Med. 2020 Mar 05;7:25
pubmed: 32195270
J Cardiovasc Magn Reson. 2022 Apr 7;24(1):25
pubmed: 35387651
Bioinformatics. 2011 Aug 15;27(16):2288-95
pubmed: 21737439
BMJ. 2021 Mar 29;372:n71
pubmed: 33782057
Nat Rev Cancer. 2018 Aug;18(8):500-510
pubmed: 29777175
Nature. 2019 Dec;576(7787):S54-S58
pubmed: 31853073
Clin Radiol. 2020 Jan;75(1):33-37
pubmed: 31079952
Radiol Artif Intell. 2020 Mar 25;2(2):e200029
pubmed: 33937821
Front Cardiovasc Med. 2022 Apr 07;9:859310
pubmed: 35463778
Obstet Gynecol. 2009 Dec;114(6):1341-1345
pubmed: 19935040
Proc Natl Acad Sci U S A. 2020 Jun 9;117(23):12592-12594
pubmed: 32457147
Radiology. 2022 Jun 14;:212929
pubmed: 35699578